A pharmaceutical composition comprising paracetamol,pseudoephedrine and loratadine

• 1. 一种以对乙酰氨基酚、氯雷他定和硫酸伪麻黄碱为活性成分的药用组合物及其制备方法、用途 [P] . 中国专利： CN1806802A . 2006-07-26
• 2. 含氯雷他定和伪麻黄碱的药物胶囊组合物 [P] . 中国专利： CN1161112C . 2004.08.11
• 3. PHARMACEUTICAL COMPOSITION COMPRISING LORATADINE, IBUPROFEN AND PSEUDOEPHEDRINE [P] . CA2054752C . 1996-12-31

  机译： 包含氯雷他定，布洛芬和伪肾上腺素的药物组合物

• 4. Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine [P] . 欧洲知识产权局专利： EP0396404B1 . 1994-02-16

  机译： 包含氯雷他定，布洛芬和伪麻黄碱的药物组合物

• 5. Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine [P] . 日本专利： JPH066536B2 . 1994-01-26

  机译： 包含氯雷他定，布洛芬和伪麻黄碱的药物组合物

• 1. Preclinical Evaluation of Pharmaceutical Compositions and Their Components for Urinary Health [J] . Francesco De Seta, Jonathan Wayne Lowery, Oladipupo Ogunbekun OMS II, 妇产科期刊（英文） . 2020,第001期
• 2. Screening Research of Pharmaceutical Compositions Based on Succinic Acid, Ascorbic Acid and Rutin [J] . Mariya Leleka, Olha Zalis＇ka, Galyna Kozyr 药剂与药理学：英文版 . 2016,第009期
• 3. Multi-component quantitation of loratadine, pseudoephedrine and paracetamol in plasma and pharmaceutical formulations with liquid chromatography-tandem mass spectrometry utilizing a monolithic column [J] . Abro K., Memon N., Bhanger M.I., Quimica nova . 2012,第10期
• 4. Multi-component quantitation of loratadine, pseudoephedrine and paracetamol in plasma and pharmaceutical formulations with liquid chromatography-tandem mass spectrometry utilizing a monolithic column [J] . Aftab Kandhro, M. I. Bhanger, Najma Memon, Química Nova . 2012,第10期
• 5. Multi-component quantitation of loratadine, pseudoephedrine and paracetamol in plasma and pharmaceutical formulations with liquid chromatography-tandem mass spectrometry utilizing a monolithic column [J] . Abro Kamran, Bhanger M. I., Industrial Research Laboratories Complex Karachi Pakistan, Quimica nova . 2012,第10期
• 6. Indirect Spectrophotometric procedures For Estimation of Paracetamol in Raw Form and in Its Pharmaceutical Preparations [C] . Qabas Naji Rashid International Conference on Materials Engineering and Science . 2020
• 7. Composition and Functional Analysis of PRC1 and Complexes Comprising SFMBT Proteins. [D] . Zhang, Jin. 2013
• 8. Development and Evaluation of a Novel Modified-Release Pellet-Based Tablet System for the Delivery of Loratadine and Pseudoephedrine Hydrochloride as Model Drugs [O] . Farrukh Zeeshan, Nadeem Irfan Bukhari 2010
• 9. Multi-component quantitation of loratadine, pseudoephedrine and paracetamol in plasma and pharmaceutical formulations with liquid chromatography-tandem mass spectrometry utilizing a monolithic column [O] . Kamran Abro, Najma Memon, M. I. Bhanger, 2012

• 1. Rapid and Sensitive CZE Method for Quality Control Analysis of Pharmaceuticals Containing Pseudoephedrine, Triprolidine and Paracetamol [J] . Sonia Di Berardino ,Renata Jasionowska . 美国分析化学（英文） . 2014,第9期
• 2. Development of a microcomposite with single-walled carbon nanotubes and Nd_2O_3 for determination of paracetamol in pharmaceutical dosage by adsorptive voltammetry [J] . Verónica Arancibia ,Johisner Penagos-Llanos ,Edgar Nagles . 药物分析学报：英文版 . 2019,第1期
• 3. An Ultra-sensitive LC Method for the Simultaneous Determination of Paracetamol, Carbamazepine, Losartan and Ciprofloxacin in Bulk Drug, Pharmaceutical Formulation and Human Serum by Programming the Detector [J] . Najma Sultana ,Muhammad Saeed Arayne ,Saeeda Nadir Ali . 美国分析化学（英文） . 2013,第1期
• 4. 可生物降解聚合物纳米胶囊型药物载体及组合胶囊的药物控制释放 [C] . 董岸杰 ,邓联东 . 2005年中德纳米生物技术国际会议 . 2005
• 5. 抗天花病毒创新药物特考韦瑞三元组合物及其增溶机制的研究 [A] . 李晓溪 . 2016